These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 12678535

  • 1. Apolipoprotein D expression in benign and malignant prostate tissues.
    Rodríguez JC, Díaz M, González LO, Sánchez J, Sánchez MT, Merino AM, Vizoso F.
    Int J Surg Investig; 2000; 2(4):319-26. PubMed ID: 12678535
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression and clinical significance of apolipoprotein D in epithelial ovarian carcinomas.
    Vázquez J, González L, Merino A, Vizoso F.
    Gynecol Oncol; 2000 Mar; 76(3):340-7. PubMed ID: 10684708
    [Abstract] [Full Text] [Related]

  • 7. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A, Burkhardt M, Jung M, Fritzsche F, Ringsdorf M, Schicktanz H, Loening SA, Kristiansen G, Jung K.
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer].
    Yang GS, Wang YM, Chen ZD.
    Zhonghua Nan Ke Xue; 2006 Feb; 12(2):137-40, 144. PubMed ID: 16519150
    [Abstract] [Full Text] [Related]

  • 11. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
    Mariani S, Salvatori L, Basciani S, Arizzi M, Franco G, Petrangeli E, Spera G, Gnessi L.
    J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA.
    Acta Oncol; 2009 Jun; 48(4):514-21. PubMed ID: 19107621
    [Abstract] [Full Text] [Related]

  • 14. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
    Monsef N, Soller M, Isaksson M, Abrahamsson PA, Panagopoulos I.
    Prostate; 2009 Jun 15; 69(9):909-16. PubMed ID: 19274762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer.
    Bouraoui Y, Ricote M, García-Tuñón I, Rodriguez-Berriguete G, Touffehi M, Rais NB, Fraile B, Paniagua R, Oueslati R, Royuela M.
    Cancer Detect Prev; 2008 Jun 15; 32(1):23-32. PubMed ID: 18400418
    [Abstract] [Full Text] [Related]

  • 17. Expression of the tumor marker D-galactose-beta-[1-->3]-N-acetyl-D-galactosamine by premalignant and malignant prostate.
    Shamsuddin AM, Beasley WM.
    Arch Pathol Lab Med; 1994 Jan 15; 118(1):48-51. PubMed ID: 7506904
    [Abstract] [Full Text] [Related]

  • 18. [P53 expression and its clinical significance in prostatic carcinoma].
    Jiang T, Jiang H, Song XS, Li XC, Li QL.
    Zhonghua Nan Ke Xue; 2005 Jun 15; 11(6):448-51, 454. PubMed ID: 15999492
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of TRAIL and its receptors in benign and malignant prostate tissues.
    Sanlioglu AD, Koksal IT, Ciftcioglu A, Baykara M, Luleci G, Sanlioglu S.
    J Urol; 2007 Jan 15; 177(1):359-64. PubMed ID: 17162091
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.
    J Pathol; 2004 Jan 15; 202(1):41-9. PubMed ID: 14694520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.